23.19
0.52%
0.12
Handel nachbörslich:
23.19
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross - MSN
Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade - Yahoo Finance
(XNCR) Proactive Strategies - Stock Traders Daily
EcoR1 Capital, LLC Increases Stake in Xencor Inc - GuruFocus.com
US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor CEO Dahiyat Bassil sells shares worth $80,841 - Investing.com
Xencor executive sells shares worth $1.6 million - Investing.com India
Xencor executive sells shares worth $1.6 million By Investing.com - Investing.com Nigeria
PRIMECAP Management Bolsters Stake in Xencor Inc - GuruFocus.com
Xencor's SWOT analysis: biotech stock faces pivotal year ahead - Investing.com
Xencor's SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com UK
Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14% - Yahoo Finance UK
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Creative Planning - Defense World
Xencor’s (XNCR) “Outperform” Rating Reiterated at BMO Capital Markets - Defense World
Xencor (NASDAQ:XNCR) Given New $28.00 Price Target at JPMorgan Chase & Co. - Defense World
Xencor (NASDAQ:XNCR) Given Outperform Rating at Wedbush - Defense World
What is Wedbush’s Forecast for Xencor FY2024 Earnings? - Defense World
Leerink Partnrs Increases Earnings Estimates for Xencor - Defense World
Leerink Partnrs Brokers Lift Earnings Estimates for Xencor - MarketBeat
What is Wedbush's Forecast for Xencor FY2024 Earnings? - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St
Xencor (NASDAQ:XNCR) Receives "Outperform" Rating from BMO Capital Markets - MarketBeat
Xencor shares target raised, rating held on pipeline progress By Investing.com - Investing.com Canada
Xencor shares target raised, rating held on pipeline progress - Investing.com
Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Xencor (NASDAQ:XNCR) shareholders are up 7.9% this past week, but still in the red over the last three years - Simply Wall St
Xencor Reports Third Quarter 2024 Financial Results - BioSpace
Xencor Inc earnings beat by $0.27, revenue fell short of estimates - Investing.com Canada
Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Xencor: Q3 Earnings Snapshot - San Antonio Express-News
Trading (XNCR) With Integrated Risk Controls - Stock Traders Daily
Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - BioSpace
Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor - IPWatchdog.com
942 in Development for Patients with Inflammatory Bowel Disease - Business Wire
Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? - Yahoo Finance
Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts - Defense World
How to Take Advantage of moves in (XNCR) - Stock Traders Daily
Essex LLC Takes Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Creative Planning Sells 3,356 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
State Street Corp's Strategic Reduction in Xencor Inc Holdings - GuruFocus.com
Wall Street Analysts Predict a 67.2% Upside in Xencor (XNCR): Here's What You Should Know - Yahoo Finance
(XNCR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):